Chemed Co. (NYSE:CHE) Shares Sold by Amundi

Amundi lowered its position in shares of Chemed Co. (NYSE:CHE) by 23.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 37,790 shares of the company’s stock after selling 11,340 shares during the quarter. Amundi owned approximately 0.25% of Chemed worth $20,105,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CHE. UMB Bank n.a. boosted its position in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Trust Co. of Vermont acquired a new stake in Chemed during the fourth quarter worth approximately $34,000. SRS Capital Advisors Inc. boosted its position in Chemed by 39.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock worth $72,000 after acquiring an additional 38 shares during the last quarter. Allworth Financial LP boosted its position in Chemed by 2,057.1% during the fourth quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after acquiring an additional 144 shares during the last quarter. Finally, KBC Group NV boosted its position in Chemed by 11.5% during the third quarter. KBC Group NV now owns 378 shares of the company’s stock worth $227,000 after acquiring an additional 39 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Transactions at Chemed

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction dated Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.

Chemed Trading Up 0.1 %

Shares of CHE stock opened at $590.03 on Friday. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The company has a market cap of $8.64 billion, a PE ratio of 29.81, a P/E/G ratio of 2.15 and a beta of 0.43. The company’s fifty day simple moving average is $557.78 and its 200-day simple moving average is $564.44.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Monday, February 24th. Chemed’s payout ratio is currently 10.05%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.